Human iPSC-derived hepatocyte-like cells support plasmodium liver-stage infection in vitro

Stem Cell Reports

Volumn 4, Issue 3, 2015, Pages 348-359

  Ng, Shengyong ^a   Schwartz, Robert E ^b,c   March, Sandra ^b,e   Galstian, Ani ^b,e   Gural, Nil ^b   Shan, Jing ^b   Prabhu, Mythili ^b   Mota, Maria M ^a,d   Bhatia, Sangeeta N ^a,b,c,e  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF LISBON   (Portugal)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; PRIMAQUINE;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CELL MATURATION; CELLS BY BODY ANATOMY; DRUG METABOLISM; DRUG RESPONSE; DRUG SCREENING; HEPATOCYTE LIKE CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER DEVELOPMENT; LIVER STAGE MALARIA; MALARIA; PARASITE DEVELOPMENT; PLASMODIUM BERGHEI; PLASMODIUM YOELII; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; INDUCED PLURIPOTENT STEM CELL; LIVER CELL; METABOLISM; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM YOELII;

ANTIMALARIALS; CELL DIFFERENTIATION; CELLS, CULTURED; HEPATOCYTES; HUMANS; IN VITRO TECHNIQUES; INDUCED PLURIPOTENT STEM CELLS; MALARIA; PLASMODIUM;

EID: 84924582240     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2015.01.002     Document Type: Article

References (35)

1. J.W. Bennett, B.S. Pybus, A. Yadava, D. Tosh, J.C. Sousa, W.F. McCarthy, G. Deye, V. Melendez, and C.F. Ockenhouse Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria N. Engl. J. Med. 369 2013 1381 1382
2. G.A. Biagini, N. Fisher, A.E. Shone, M.A. Mubaraki, A. Srivastava, A. Hill, T. Antoine, A.J. Warman, J. Davies, and C. Pidathala Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria Proc. Natl. Acad. Sci. USA 109 2012 8298 8303
3. L. Cui, A.A. Escalante, M. Imwong, and G. Snounou The genetic diversity of Plasmodium vivax populations Trends Parasitol. 19 2003 220 226
4. F.P. da Cruz, C. Martin, K. Buchholz, M.J. Lafuente-Monasterio, T. Rodrigues, B. Sönnichsen, R. Moreira, F.-J. Gamo, M. Marti, and M.M. Mota Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug J. Infect. Dis. 205 2012 1278 1286
5. L. Dembele, A. Gego, A.-M. Zeeman, J.-F. Franetich, O. Silvie, A. Rametti, R. Le Grand, N. Dereuddre-Bosquet, R. Sauerwein, and G.-J. van Gemert Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery PLoS ONE 6 2011 e18162
6. E.R. Derbyshire, M. Prudêncio, M.M. Mota, and J. Clardy Liver-stage malaria parasites vulnerable to diverse chemical scaffolds Proc. Natl. Acad. Sci. USA 109 2012 8511 8516
7. A.M. Dondorp, F. Nosten, P. Yi, D. Das, A.P. Phyo, J. Tarning, K.M. Lwin, F. Ariey, W. Hanpithakpong, and S.J. Lee Artemisinin resistance in Plasmodium falciparum malaria N. Engl. J. Med. 361 2009 455 467
8. S.J. Engle, and D. Puppala Integrating human pluripotent stem cells into drug development Cell Stem Cell 12 2013 669 677
9. S. Gunawardena, N.D. Karunaweera, M.U. Ferreira, M. Phone-Kyaw, R.J. Pollack, M. Alifrangis, R.S. Rajakaruna, F. Konradsen, P.H. Amerasinghe, and M.L. Schousboe Geographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia Am. J. Trop. Med. Hyg. 82 2010 235 242
10. X. Jin, B.S. Pybus, R. Marcsisin, T. Logan, T.L. Luong, J. Sousa, N. Matlock, V. Collazo, C. Asher, and D. Carroll An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model Eur. J. Drug Metab. Pharmacokinet. 39 2014 139 146
11. S. Khoo, D. Back, and P. Winstanley The potential for interactions between antimalarial and antiretroviral drugs AIDS 19 2005 995 1005
12. J. Li, W.E. Collins, R.A. Wirtz, D. Rathore, A. Lal, and T.F. McCutchan Geographic subdivision of the range of the malaria parasite Plasmodium vivax Emerg. Infect. Dis. 7 2001 35 42
13. S. March, S. Ng, S. Velmurugan, A. Galstian, J. Shan, D.J. Logan, A.E. Carpenter, D. Thomas, B.K.L. Sim, and M.M. Mota A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax Cell Host Microbe 14 2013 104 115
14. D. Mazier, L. Rénia, and G. Snounou A pre-emptive strike against malaria's stealthy hepatic forms Nat. Rev. Drug Discov. 8 2009 854 864
15. M.E. McDonnell, and L.E. Braverman Drug-related hepatotoxicity N. Engl. J. Med. 354 2006 2191 2193 author reply 2191-2193
16. S. Meister, D.M. Plouffe, K.L. Kuhen, G.M. Bonamy, T. Wu, S.W. Barnes, S.E. Bopp, R. Borboa, A.T. Bright, and J. Che Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery Science (80-.). 334 2011 1372 1377
17. J.L. Miller, S. Murray, A.M. Vaughan, A. Harupa, B. Sack, M. Baldwin, I.N. Crispe, and S.H.I. Kappe Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii PLoS ONE 8 2013 e60820
18. A. Mwakingwe, L.-M. Ting, S. Hochman, J. Chen, P. Sinnis, and K. Kim Noninvasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites J. Infect. Dis. 200 2009 1470 1478
19. S. Ogawa, J. Surapisitchat, C. Virtanen, M. Ogawa, M. Niapour, K.S. Sugamori, S. Wang, L. Tamblyn, C. Guillemette, and E. Hoffmann Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes Development 140 2013 3285 3296
20. M. Prudêncio, A. Rodriguez, and M.M. Mota The silent path to thousands of merozoites: the Plasmodium liver stage Nat. Rev. Microbiol. 4 2006 849 856
21. B.S. Pybus, J.C. Sousa, X. Jin, J.A. Ferguson, R.E. Christian, R. Barnhart, C. Vuong, R.J. Sciotti, G.A. Reichard, and M.P. Kozar CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine Malar. J. 11 2012 259
22. B.S. Pybus, S.R. Marcsisin, X. Jin, G. Deye, J.C. Sousa, Q. Li, D. Caridha, Q. Zeng, G.A. Reichard, and C. Ockenhouse The metabolism of primaquine to its active metabolite is dependent on CYP 2D6 Malar. J. 12 2013 212
23. R. Schwartz, K. Trehan, L. Andrus, T.P. Sheahan, A. Ploss, S.A. Duncan, C.M. Rice, and S.N. Bhatia Modeling hepatitis C virus infection using human induced pluripotent stem cells Proc. Natl. Acad. Sci. USA 109 2012 2544 2548
24. R.E. Schwartz, H.E. Fleming, S.R. Khetani, and S.N. Bhatia Pluripotent stem cell-derived hepatocyte-like cells Biotechnol. Adv. 32 2014 504 513
25. J. Shan, R.E. Schwartz, N.T. Ross, D.J. Logan, D. Thomas, S.A. Duncan, T.E. North, W. Goessling, A.E. Carpenter, and S.N. Bhatia Identification of small molecules for human hepatocyte expansion and iPS differentiation Nat. Chem. Biol. 9 2013 514 520
26. A. Shlomai, R.E. Schwartz, V. Ramanan, A. Bhatta, Y.P. de Jong, S.N. Bhatia, and C.M. Rice Modeling host interactions with hepatitis B virus using primary and iPSC-derived hepatocellular systems Proc. Natl. Acad. Sci. USA 111 2014 12193 12198
27. K. Si-Tayeb, F.K. Noto, M. Nagaoka, J. Li, M.A. Battle, C. Duris, P.E. North, S. Dalton, and S.A. Duncan Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells Hepatology 51 2010 297 305
28. A. Somers, J.-C. Jean, C.A. Sommer, A. Omari, C.C. Ford, J.A. Mills, L. Ying, A.G. Sommer, J.M. Jean, and B.W. Smith Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette Stem Cells 28 2010 1728 1740
29. Z. Song, J. Cai, Y. Liu, D. Zhao, J. Yong, S. Duo, X. Song, Y. Guo, Y. Zhao, and H. Qin Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells Cell Res. 19 2009 1233 1242
30. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
31. K. Takayama, M. Inamura, K. Kawabata, K. Katayama, M. Higuchi, K. Tashiro, A. Nonaka, F. Sakurai, T. Hayakawa, M.K. Furue, and H. Mizuguchi Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction Mol. Ther. 20 2012 127 137
32. T. Takebe, K. Sekine, M. Enomura, H. Koike, M. Kimura, T. Ogaeri, R.-R. Zhang, Y. Ueno, Y.-W. Zheng, and N. Koike Vascularized and functional human liver from an iPSC-derived organ bud transplant Nature 499 2013 481 484
33. J. a. Thomson Embryonic Stem Cell Lines Derived from Human Blastocysts Science (80-.). 282 1998 1145 1147
34. T.N.C. Wells, P.L. Alonso, and W.E. Gutteridge New medicines to improve control and contribute to the eradication of malaria Nat. Rev. Drug Discov. 8 2009 879 891
35. World Health Organization (2013). World malaria report 2013.